The Society for Human Resource Management calls attention to the fact that the House-passed bill addressing the opioid crisis (H.R. 6) “contains a provision extending the amount of time that employer-sponsored health plans [including FEHB plans] must cover end-stage renal disease under Medicare secondary payer rules from 30 months to 33 months.” That would be a bitter pill for those plans to swallow on top of the high cost of the opioid crisis itself.
The Washington Examiner reports that several prescription drug manufacturer are continuing their unpopular practice of semi-annual pricing changes.
CNBC, via Becker’s Hospital Review, tells us that telemedicine faces obstacles on its path to reaching the mainstream of healthcare. AHIP points out in this article how telemedicine can be interwoven current focus on social determinants of health. The FEHBlog believes that eventually telemedicine will reach the mainstream.
Meanwhile the International Foundation reports
Onsite [health] clinics are not a new concept, but they are gaining increasing popularity with employers of all sizes. Because these clinics provide primary care and preventative care, onsite clinics are a multifaceted solution used by employers to decrease costs, increase access to care, improve health outcomes for their employees, and create a more productive and satisfied workforce.
In fact, more than 40 companies on Fortune’s list of the “100 Best Companies to Work For” offer an onsite health clinic for their employees. Additionally, according to the National Survey of Onsite Clinic Operations and Policies Report published in December of 2014, 66% of onsite health center programs demonstrated its ROI in all or some areas.
Federal agencies offer on-site medical clinics but they don’t coordinate care with FEHB plans.